Hi, what are you looking for?
– Teva earned lower profits on flat revenue for 2013, but beat the analysts’ consensus. – Please help us out : Will you offer...
– – U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) new dose of COPAXONE drug application (sNDA) for three-times-a-week 40mg/mL....
– Europe’s Committee for Medicinal Products for Human Use: The risk-benefit profile of laquinimod is not favorable at this time. – – Teva Pharmaceutical...
– Teva expects the Supreme Court to hear the case in April, a month before the Copaxone patents expire. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Press Release JERUSALEM–(BUSINESS WIRE)–Jan. 21, 2014– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that it has entered into a definitive agreement under which Teva...
– Bonuses could boost Erez Vigodman’s compensation to $4.1 million annually, not including options. – – The basic salary of incoming Teva Pharmaceutical Industries Ltd. (NYSE:TEVA;...
– Acting CEO Eyal Desheh: We are committed to reducing costs by $2 billion and moving production from the US to Europe and Asia....
– – Teva Pharmaceutical Industries Ltd. (TEVA), the world’s biggest generic drugmaker, has won a patent infringement case on generic painkiller OxyContin filed by...
– – Teva Pharmaceutical Industries Ltd (NYSE:TEVA) today announced that Erez Vigodman, 54, has been appointed President and Chief Executive Officer, effective February 11,...
– In a notice to the SEC, biotech company NuPathe said that Teva is offering $3.65 per share, compared with yesterday’s closing price of...